Evidence map›Paper›PMID 36548255›Full record

ArticlePloS one2022

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.

Ashley H Beecham, Lilyana Amezcua, Angel Chinea, Clara P Manrique, Lissette Gomez, Andrea Martinez, Gary W Beecham, Nikolaos A Patsopoulos, Tanuja Chitnis, Howard L Weiner and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The immunopathogenesis of narcolepsy type 1.Nature reviews. Immunology · 2024
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Ashley H BeechamJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.ORCID 0000-0003-4349-4584
Lilyana AmezcuaDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Angel ChineaSan Juan MS Center, Guaynabo, Puerto Rico, United States of America.
Clara P ManriqueJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Lissette GomezJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Andrea MartinezDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Gary W BeechamJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Nikolaos A PatsopoulosAnn Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
Tanuja ChitnisAnn Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
Howard L WeinerAnn Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
Philip L De JagerCenter For Translational & Computational Neuroimmunology and the Multiple Sclerosis Center, Department of Neurology, Columbia University Irving Medical Center, New York, NY, United States of America.
Esteban G BurchardDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States of America.
Brett T LundDepartment of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Kathryn C FitzgeraldDepartment of Neurology and The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.ORCID 0000-0003-3137-0322
Peter A CalabresiDepartment of Neurology and The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Silvia R DelgadoMultiple Sclerosis Division, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Jorge R OksenbergDepartment of Neurology, University of California, San Francisco, San Francisco, CA, United States of America.
Jacob L McCauleyJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.ORCID 0000-0002-1805-1733
University of Miami · USBrigham and Women's Hospital · USUniversity of Southern California · USJohns Hopkins University · USUniversity of California, San Francisco · USColumbia University · US

Funding

Imaging Neurodegeneration in Multiple SclerosisR01NS082347 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PETER A CALABRESI, Shiv Saidha · 2013 to 2026
$7.0M
GENE LINKAGE STUDY OF MULTIPLE SCLEROSIS SIBLING PAIRSR01NS026799 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L, OKSENBERG, JORGE R. · 1989 to 2018
$6.8M
Individualized Risk Stratification Using the Genomic ContributionR01HL102487 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BEECHAM, GARY WAYNE, SEO, DAVID M · 2010 to 2014
$3.7M
Genetic and Phenotypic Analysis of Multiple Sclerosis in HispanicsR01NS096212 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MCCAULEY, JACOB L · 2016 to 2021
$3.1M
Southern California Clinical and Translational Science InstituteKL2TR000131 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$2.1M
NCATS NIH HHS KL2 TR000131NHLBI NIH HHS R01 HL102487NINDS NIH HHS R01 NS026799NINDS NIH HHS R01 NS082347NINDS NIH HHS R01 NS096212
6 · The paper itself

Abstract

The Major Histocompatibility Complex (MHC) makes the largest genetic contribution to multiple sclerosis (MS) susceptibility, with 32 independent effects across the region explaining 20% of the heritability in European populations. Variation is high across populations with allele frequency differences and population-specific risk alleles identified. We sought to identify MHC-specific MS susceptibility variants and assess the effect of ancestral risk modification within 2652 Latinx and Hispanic individuals as well as 2435 Black and African American individuals. We have identified several novel susceptibility alleles which are rare in European populations including HLA-B*53:01, and we have utilized the differing linkage disequilibrium patterns inherent to these populations to identify an independent role for HLA-DRB1*15:01 and HLA-DQB1*06:02 on MS risk. We found a decrease in Native American ancestry in MS cases vs controls across the MHC, peaking near the previously identified MICB locus with a decrease of ~5.5% in Hispanics and ~0.4% in African Americans. We have identified several susceptibility variants, including within the MICB gene region, which show global ancestry risk modification and indicate ancestral differences which may be due in part to correlated environmental factors. We have also identified several susceptibility variants for which MS risk is modified by local ancestry and indicate true ancestral genetic differences; including HLA-DQB1*06:02 for which MS risk for European allele carriers is almost two times the risk for African allele carriers. These results validate the importance of investigating MS susceptibility at an ancestral level and offer insight into the epidemiology of MS phenotypic diversity.

Indexed as

Genetic Predisposition to DiseaseMajor Histocompatibility ComplexMultiple SclerosisAfrican PeopleAllelesEuropean PeopleGene FrequencyHaplotypesHLA-DRB1 ChainsHumansLinkage DisequilibriumRiskHLA-DRB1 Chains

Identifiers

PMID36548255
PMCPMC9778564
OpenAlexW4312091472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.